Answers are grounded in this paper and cite their sources.
Inhaled medications are the cornerstone of COPD management, yet poor adherence remains common and may be particularly problematic after acute exacerbations of COPD (AECOPD). Evidence on adherence to inhaled therapy among Chinese patients hospitalized for AECOPD remains limited. this analysis was derived from a multicenter, prospective, observational cohort study conducted in eight hospitals across eight Chinese provinces between 2022 and 2023. Patients hospitalized for AECOPD were enrolled and followed for 30 ± 2 days after discharge. Adherence to inhaled medications was assessed using the 10-item Test of Adherence to Inhalers (TAI); good adherence was defined as a TAI-10 score of 50, intermediate adherence as 46–49, and poor adherence as ≤45. Demographic characteristics, COPD history, clinical characteristics, and treatment data were collected during hospitalization and at follow-up. Univariable and multivariable binary logistic regression analyses were performed to identify factors associated with good adherence, and multiple imputation was used in sensitivity analyses to address missing pulmonary function data. of the 573 recruited patients, 541 were included in the final analysis. Within 30 days after discharge, 35.5% of patients were poor adherent and 18.3% were intermediate adherent to inhaled medications, including 14.1% who had discontinued use. Overall, 87.1% had CAT scores ≥10, 78.6% had mMRC scores ≥2 during hospitalization, and 71.7% had experienced at least one exacerbation in the previous year. In univariable analysis, Group E, CAT score ≥10, and mMRC score ≥2 were associated with good adherence, whereas current smoking and initial diagnosis were associated with poor adherence. In the multivariable logistic regression model, a CAT score ≥10 remained independently associated with better adherence, while current smoking remained independently associated with poorer adherence; these associations were confirmed in sensitivity analyses using imputed data. approximately one-third of patients recently hospitalized for AECOPD were poor adherence to inhaled medications 30 days after discharge. A greater symptom burden (CAT ≥ 10) was associated with better adherence, whereas current smoking was associated with poorer adherence. Targeted education and follow-up, particularly for patients who smoke, are warranted to improve adherence to inhaled medications and may help reduce future exacerbations and the overall disease burden of COPD.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: